Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary G-CSF Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Breast Cancer Patients at Risk of Febrile Neutropenia

NCT00536081 is registered in ClinicalTrials.gov with Academisch Ziekenhuis Maastricht as lead sponsor.

NCT NCT00536081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00536081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary G-CSF Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Breast Cancer Patients at Risk of Febrile Neutropenia
Lead sponsor
Academisch Ziekenhuis Maastricht
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
December 1, 2016
Enrollment
172 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapy, febrile neutropenia